Evidence map›Paper›PMID 25794007›Full record

ArticlePLoS pathogens2015

An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.

Mariaelena Caboni, Thierry Pédron, Omar Rossi, David Goulding, Derek Pickard, Francesco Citiulo, Calman A MacLennan, Gordon Dougan, Nicholas R Thomson, Allan Saul and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Development of a NovelVaccines · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A cell-cell communication signal fromApplied and environmental microbiology · 2025
    Article
  11. Review
  12. Vaccines · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Immunogenicity evaluation of altSonflex1-2-3Frontiers in immunology · 2025
    Article
  17. SPATEs promote the survival ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. O26 Polysaccharides as Key Players in EnteropathogenicInternational journal of molecular sciences · 2024
    Article
  20. Microbiology (Reading, England) · 2024
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Mariaelena CaboniNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
Thierry PédronInstitut Pasteur, Unité de Pathogénie Microbienne Moléculaire, INSERM U1202, Paris, France.
Omar RossiNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
David GouldingWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Derek PickardWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Francesco CitiuloNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
Calman A MacLennanNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
Gordon DouganWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Nicholas R ThomsonWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Allan SaulNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
Philippe J SansonettiInstitut Pasteur, Unité de Pathogénie Microbienne Moléculaire, INSERM U1202, Paris, France; Collège de France, Chaire de Microbiologie et Maladies Infectieuses, Paris, France.
Christiane GerkeNovartis Vaccines Institute for Global Health, Siena, Via Fiorentina, Italy.
Toscana Life Sciences · ITWellcome Sanger Institute · GBInserm · FRNovartis (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shigella is the leading cause for dysentery worldwide. Together with several virulence factors employed for invasion, the presence and length of the O antigen (OAg) of the lipopolysaccharide (LPS) plays a key role in pathogenesis. S. flexneri 2a has a bimodal OAg chain length distribution regulated in a growth-dependent manner, whereas S. sonnei LPS comprises a monomodal OAg. Here we reveal that S. sonnei, but not S. flexneri 2a, possesses a high molecular weight, immunogenic group 4 capsule, characterized by structural similarity to LPS OAg. We found that a galU mutant of S. sonnei, that is unable to produce a complete LPS with OAg attached, can still assemble OAg material on the cell surface, but a galU mutant of S. flexneri 2a cannot. High molecular weight material not linked to the LPS was purified from S. sonnei and confirmed by NMR to contain the specific sugars of the S. sonnei OAg. Deletion of genes homologous to the group 4 capsule synthesis cluster, previously described in Escherichia coli, abolished the generation of the high molecular weight OAg material. This OAg capsule strongly affects the virulence of S. sonnei. Uncapsulated knockout bacteria were highly invasive in vitro and strongly inflammatory in the rabbit intestine. But, the lack of capsule reduced the ability of S. sonnei to resist complement-mediated killing and to spread from the gut to peripheral organs. In contrast, overexpression of the capsule decreased invasiveness in vitro and inflammation in vivo compared to the wild type. In conclusion, the data indicate that in S. sonnei expression of the capsule modulates bacterial pathogenesis resulting in balanced capabilities to invade and persist in the host environment.

Indexed as

AnimalsBacterial CapsulesGene Knockdown TechniquesO AntigensRabbitsShigella sonneiO Antigens

Identifiers

PMID25794007
PMCPMC4368438
OpenAlexW2011258278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.